HIGHLIGHTS
- who: Pengfei Qiao and Zhentao Tian from the Nankai University, China have published the Article: Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27, in the Journal: (JOURNAL)
- what: This study investigated the molecular mechanism of ATL-1 inhibiting the proliferation of prostate cancer cells. The results of enrichment analysis showed that EIF4E overexpression was associated with tumor drug resistance. this study, the mechanism of ATL-1 regulating Bcl-2/Bax signaling pathway on tumor cells was investigated.
- how: Immunohistochemical staining results showed that Hsp27 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.